Skip to main content
Explore URMC

Head and Neck Cancer: Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IV Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery

Research Question:
Do the changes in a gene called TP53 influence the response to radiation therapy alone or radiation therapy in combination with cisplatin chemotherapy?

Basic Study Information

The purpose of this study is to compare two treatment approaches that are currently used after surgery for head and neck cancer. One approach is to administer radiation therapy alone. A second approach is to administer radiation therapy along with the chemotherapy drug, cisplatin.

Location: Cancer Center
Study Web URL:
Study Reference #: CHAN17022

Lead Researcher (Principal Investigator)

Lead Researcher:  Ronald Maggiore

Study Contact Information

Study Coordinator: Park Bogan
Phone: (585) 276-4415

Additional Study Details

Learn More About These Conditions

More information about Carcinoma, Squamous Cell

Return to Search